human technology (175140) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for human technology is dated 2024-03-11; the most recent is 2025-03-05. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea).
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2025-03-05 | BUY | 제3자배정유상증자 | 문성원 Seongwon Moon | Internal director | 1.0M | ₩6,170 | -35.7% | ₩6.4B ($4.5M) |
| 2024-04-04 | SELL | 장외매도 | 메타케어 metacare | - | -200.0K | ₩4,760 | +16.6% | ₩952M ($661K) |
| 2024-04-04 | SELL | 장외매도 | 메타케어 metacare | - | -200.0K | ₩4,760 | +16.6% | ₩952M ($661K) |
| 2024-04-04 | SELL | 장외매도 | 메타케어 metacare | - | -200.0K | ₩4,760 | +16.6% | ₩952M ($661K) |
| 2024-04-02 | SELL | 장외매도 | 메타케어 metacare | - | -200.0K | ₩4,810 | +17.5% | ₩962M ($668K) |
| 2024-04-02 | SELL | 장외매도 | 메타케어 metacare | - | -259.3K | ₩4,810 | +17.5% | ₩1.2B ($866K) |
| 2024-03-27 | SELL | 장외매도 | 메타케어 metacare | - | -600.0K | ₩5,200 | +23.6% | ₩3.1B ($2.2M) |
| 2024-03-27 | SELL | 장외매도 | 메타케어 metacare | - | -654.3K | ₩5,200 | +23.6% | ₩3.4B ($2.4M) |
| 2024-03-27 | SELL | 장외매도 | 메타케어 metacare | - | -86.4K | ₩5,200 | +23.6% | ₩449M ($312K) |
| 2024-03-26 | SELL | 장외매도 | 메타케어 metacare | - | -400.0K | ₩4,990 | +20.4% | ₩2.0B ($1.4M) |
| 2024-03-25 | SELL | 장외매도 | 메타케어 metacare | - | -300.0K | ₩4,870 | +18.5% | ₩1.5B ($1.0M) |
| 2024-03-25 | SELL | 장외매도 | 메타케어 metacare | - | -700.0K | ₩4,870 | +18.5% | ₩3.4B ($2.4M) |
| 2024-03-12 | BUY | 유상신주취득 | 휴먼테크조합 Human Tech Association | - | 5.1M | ₩4,070 | -2.5% | ₩20.9B ($14.5M) |
| 2024-03-11 | SELL | 장외매도 | 메타케어 metacare | - | -1.0M | ₩4,970 | +20.1% | ₩5.0B ($3.5M) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for human technology. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.